Page last updated: 2024-08-23

bambuterol and Lung Diseases, Obstructive

bambuterol has been researched along with Lung Diseases, Obstructive in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allen, D; Bowes, G; Bowler, S; Breslin, AB; Frith, P; McDonald, CF; Murree-Allen, K; Musk, AW; Pierce, RJ; Saunders, N; Thompson, PJ1
Calderaro, F; Califano, C; Cazzola, M; Di Pema, F; Donner, CF; Matera, MG; Vinciguerra, A1

Trials

2 trial(s) available for bambuterol and Lung Diseases, Obstructive

ArticleYear
Comparison of oral bambuterol and terbutaline in elderly patients with chronic reversible airflow obstruction.
    The Journal of asthma : official journal of the Association for the Care of Asthma, 1997, Volume: 34, Issue:1

    Topics: Administration, Oral; Aged; Aged, 80 and over; Analysis of Variance; Bronchodilator Agents; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Humans; Lung Diseases, Obstructive; Middle Aged; Statistics, Nonparametric; Terbutaline; Treatment Outcome

1997
Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease.
    European journal of clinical pharmacology, 1999, Volume: 54, Issue:11

    Topics: Administration, Inhalation; Administration, Oral; Adult; Aged; Albuterol; Arrhythmias, Cardiac; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Forced Expiratory Flow Rates; Forced Expiratory Volume; Heart Rate; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Salmeterol Xinafoate; Terbutaline; Time Factors; Tremor

1999